History
# Registration date Revision Id
3 2025-05-08, 1404/02/18 339579
2 2025-04-22, 1404/02/02 339080
1 2022-03-18, 1400/12/27 220387
Changes made to previous revision
  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents
  • Health conditions studied

    #1
    8B11
    E08.31
    Cerebral ischaemic stroke
    Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy
    Stroke
    Diabetic Retinopathy
    استروک
    رتینوپاتی دیابتی
  • Primary outcomes

    #1
    Visual field
    Inflammatory/Anti Inflammatory factors
    میدان بینایی
    فاکتورهای التهابی
    Monthly
    pre and post Treatment
    ماهیانه
    قبل و بعد درمان
    perimetry
    Elisa Kits
    پریمتری
    کیت الیزا
    #2
    empty
    Oxidant /Anti Oxidant Factors
    empty
    فاکتورهای اکسیدانی
    empty
    pre and post Treatment
    empty
    قبل و بعد درمان
    empty
    Elisa kits
    empty
    کیت الیزا
    #3
    empty
    serum Beta secretase activity
    empty
    فعالیت بتا سکرتاز سرم
    empty
    pre and post Treatment
    empty
    قبل و بعد درمان
    empty
    Elisa Kit
    empty
    کیت الیزا
  • Secondary outcomes

    #1
    serum beta secretase
    Blood pressure
    بتا سکرتاز سرمی
    فشار خون
    Monthly
    pre and post Treatment
    ماهیانه
    قبل و بعد درمان
    Assay kit
    Standard Barometer
    کیت
    فشار سنج جیوه ای استاندارد
    #2
    Quality of life based on vision
    empty
    کیفیت زندگی بر اساس بینایی
    empty
    Monthly
    empty
    ماهیانه
    empty
    questionnaire
    empty
    پرسشنامه
    empty
    #3
    Contrast sensitivity
    empty
    تست حساسیت کنتراست
    empty
    monthly
    empty
    ماهیانه
    empty
    Freiburg CS Test
    empty
    تست کنتراست فرایبورگ
    empty
    #4
    oxidant Status
    empty
    وضعیت اکسیدانی
    empty
    Monthly
    empty
    ماهیانه
    empty
    Assay kit
    empty
    کیت
    empty
    #5
    Antioxidant Status
    empty
    وضعیت آنتی اکسیدانی
    empty
    Monthly
    empty
    ماهیانه
    empty
    Assay kit
    empty
    کیت
    empty
    #6
    Visual Acuity
    empty
    حدت بینایی
    empty
    Weekly
    empty
    هفتگی
    empty
    Snellen chart
    empty
    اسنلن چارت
    empty
  • Intervention groups

    #1
    Intervention group:Patients will be treated with Coenzyme Q10 soft gel prepared from jalinus Pharmaceutical Company (Tehran-Iran),orally (10 mg/kg), daily for 30 days
    Intervention group:Patients will be treated with Coenzyme Q10 soft gel prepared from jalinus Pharmaceutical Company (Tehran-Iran),orally (200mg), daily for 120 days
    گروه مداخله: سافت ژل کوانزیم کیوتن تهیه شده از شرکت داروسازی جالینوس(ایران-تهران)،بصورت خوراکی به میزان ۱۰میلی گرم به ازای هرکیلوگرم وزن روزانه و به مدت ۳۰ روز
    گروه مداخله: سافت ژل کوانزیم کیوتن تهیه شده از شرکت داروسازی جالینوس(ایران-تهران)،بصورت خوراکی به میزان ۲۰۰ میلی گرم روزانه و به مدت 120روز
    #2
    گروه کنترل: بیماران با دارونما با همان شکل ظاهری و بصورت خوراکی به مدت ۳۰ روز درمان خواهند شد.
    گروه کنترل: بیماران با دارونما با همان شکل ظاهری و بصورت خوراکی به مدت 120 روز درمان خواهند شد.
  • Recruitment centers

    #1
    Name of recruitment center - English: Shahid Beheshti Hospital
    Name of recruitment center - Persian: بیمارستان شهید بهشتی
    Full name of responsible person - English: Ehsan Sharifipour
    Full name of responsible person - Persian: احسان شریفی پور
    Street address - English: Shahid Beheshti
    Street address - Persian: شهید بهشتی
    City - English: Qom
    City - Persian: قم
    Province: Ghoum
    Country: Iran (Islamic Republic of)
    Postal code: 3716993456
    Phone: +98 25 3285 2720
    Fax:
    Email: sharifipour.e@yahoo.com
    Web page address:
    Name of recruitment center - English: Taban Eye Clinic
    Name of recruitment center - Persian: کلینیک چشم پزشکی تابان
    Full name of responsible person - English: Fatemeh Javadian
    Full name of responsible person - Persian: فاطمه جوادیان
    Street address - English: Boo Ali Sina
    Street address - Persian: بوعلی سینا
    City - English: Qom
    City - Persian: قم
    Province: Ghoum
    Country: Iran (Islamic Republic of)
    Postal code: 3716615198
    Phone: +98 25 3294 5000
    Fax:
    Email: tabanCl-Qom@gmail.com
    Web page address:
  • Person responsible for general inquiries


    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Ehsan Sharifipour
    Full name of responsible person - Persian: احسان شریفی پور
    Position - English: Associate Professor
    Position - Persian: دانشیار
    Latest degree: specialist
    Area of specialty/work: 86
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: Safa Shahr
    Street address - Persian: صفاشهر
    City - English: Qom
    City - Persian: قم
    Province: Ghoum
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code: 3716993456
    Phone: +98 25 3285 2720
    Mobile: +98 912 503 5828
    Fax:
    Email: sharifipour.e@yahoo.com
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Abdolrahman Sarihi
    Full name of responsible person - Persian: عبدالرحمن صریحی
    Position - English: Professor
    Position - Persian: استاد
    Latest degree: phd
    Area of specialty/work: 63
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: Pajoohesh
    Street address - Persian: پژوهش
    City - English: Hamadan
    City - Persian: همدان
    Province: Hamadan
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code: ۶۵۱۷۸۳۸۷۳۶
    Phone: +98 81 3131 0000
    Mobile: +98 913122098
    Fax:
    Email: sarihi@umsha.ac.ir
    Web page address:

Protocol summary

Study aim
The aim of this study was to investigate the role of coenzyme Q10 in improve of Inflammatory and oxidative status and beta-secretase level in diabetic retinopathy patients.
Design
At the beginning of the study cognition status as well as serum beta-secretase levels and inflammatory and oxidant and antioxidant status of patients are evaluated. Treatment for three month in two groups:1) oral coenzyme Q10,200 mg daily and 2)Placebo will be done. At the end, the mentioned factors will be measured again and possible changes will be analyzed based on statistical calculations.
Settings and conduct
Cognitive status will be assessed using standard questionnaires. serum Beta-secretase levels and oxidation status will be determined by the relevant kits according to approved protocols. The study will be performed at Taban eye clinic in Qom Province.
Participants/Inclusion and exclusion criteria
Age between 40 and 75 years Blood pressure and glucose under control Adequate level of awareness and cognition exclude : neurological disease such as Alzheimer's, Parkinson's, cognitive impairment and MS. irreversible other eye disease such as glaucoma, cataracts, etc. Consumption of other antioxidant drugs such as vitamins E, C and A, etc. Taking immunosuppressive drugs for the past two months Patients with uncontrolled diabetes and Hypertension
Intervention groups
1)Coenzyme Q10 ,n=32 2)Placebo ,n=32
Main outcome variables
Inflammatory and oxidant factors and beta secretase activity levels of serum

General information

Reason for update
change in proposal For operational and feasibility reasons
Acronym
IRCT registration information
IRCT registration number: IRCT20160524028046N2
Registration date: 2022-03-18, 1400/12/27
Registration timing: prospective

Last update: 2025-05-12, 1404/02/22
Update count: 2
Registration date
2022-03-18, 1400/12/27
Registrant information
Name
Mohammad Hossein Sharif
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 81 3252 0182
Email address
mhsharif2013@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-04-04, 1402/01/15
Expected recruitment end date
2026-03-06, 1404/12/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation the effect of coenzyme Q10 and placebo on blood inflammatory and oxidant factors and beta-secretase activity levels in diabetic retinopathy patients
Public title
Evaluation the effect of coenzyme Q10 on blood inflammatory and oxidant factors and beta-secretase activity levels in diabetic retinopathy patients
Purpose
Health service research
Inclusion/Exclusion criteria
Inclusion criteria:
diabetic retinopathy patients
Exclusion criteria:
Other effective ocular disease and neurological diseases such as Alzheimer's and MS
Age
From 40 years old to 75 years old
Gender
Both
Phase
2-3
Groups that have been masked
  • Participant
  • Investigator
  • Outcome assessor
Sample size
Target sample size: 64
Randomization (investigator's opinion)
Randomized
Randomization description
According to the method of random allocation rule, 32 balls called treatment group and 32 balls called placebo are mixed with each other and randomly removed one by one. The removed ball will not be replaced.
Blinding (investigator's opinion)
Double blinded
Blinding description
The study will be duble blinded. Patients will be blinded to the type of intervention and the researcher who must evaluate and record the data will be blinded to the type of intervention.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Hamadan University of Medical Sciences
Street address
Pajoohesh
City
Hamedan
Province
Hamadan
Postal code
6517838736
Approval date
2022-03-06, 1400/12/15
Ethics committee reference number
IR.UMSHA.REC.1400.969

Health conditions studied

1

Description of health condition studied
Diabetic Retinopathy
ICD-10 code
E08.31
ICD-10 code description
Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy

Primary outcomes

1

Description
Inflammatory/Anti Inflammatory factors
Timepoint
pre and post Treatment
Method of measurement
Elisa Kits

2

Description
Oxidant /Anti Oxidant Factors
Timepoint
pre and post Treatment
Method of measurement
Elisa kits

3

Description
serum Beta secretase activity
Timepoint
pre and post Treatment
Method of measurement
Elisa Kit

Secondary outcomes

1

Description
Blood pressure
Timepoint
pre and post Treatment
Method of measurement
Standard Barometer

Intervention groups

1

Description
Intervention group:Patients will be treated with Coenzyme Q10 soft gel prepared from jalinus Pharmaceutical Company (Tehran-Iran),orally (200mg), daily for 120 days
Category
Treatment - Drugs

2

Description
Control group: Placebo
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Taban Eye Clinic
Full name of responsible person
Fatemeh Javadian
Street address
Boo Ali Sina
City
Qom
Province
Ghoum
Postal code
3716615198
Phone
+98 25 3294 5000
Email
tabanCl-Qom@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
Abdolrahman Sarihi
Street address
Pajoohesh
City
Hamedan
Province
Hamadan
Postal code
۶۵۱۷۸۳۸۷۳۶
Phone
+98 81 3131 0000
Email
sarihi@umsha.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Hamedan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
Abdolrahman Sarihi
Position
Professor
Latest degree
Ph.D.
Other areas of specialty/work
Neuroscience
Street address
Pajoohesh
City
Hamadan
Province
Hamadan
Postal code
۶۵۱۷۸۳۸۷۳۶
Phone
+98 81 3131 0000
Email
sarihi@umsha.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
َAbdolrahman Sarihi
Position
Professor
Latest degree
Ph.D.
Other areas of specialty/work
Physiology
Street address
Pajoohesh
City
Hamedan
Province
Hamadan
Postal code
۶۵۱۷۸۳۸۷۳۶
Phone
+98 81 3131 0000
Email
sarihi@umsha.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Hamedan University of Medical Sciences
Full name of responsible person
Mohamad Hossein Sharif
Position
PhD Student
Latest degree
Master
Other areas of specialty/work
Neuroscience
Street address
Pajoohesh
City
Hamedan
Province
Hamadan
Postal code
۶۵۱۷۸۳۸۷۳۶
Phone
+98 81 3131 0000
Email
mhsharif2013@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...